I International Conference for Alernatives to Animal Experimentation
II International Conference Of
Alternatives to Animal Experimentation

Portugal, 8th, 9th May, 2015

If you would like to get updates on the conference please leave us your e-mail

Preliminary Programme

8TH MAY 2015

09h00 - 10h00 Registration
10h00 - 10h30 Opening Session
Representatives from the Lisbon City Hall, DGAV
(Ministry of Agriculture, Sea, Environment and Land Planning)
and the Portuguese Veterinary Order

SESSION 1 - Animal Experimentation: Past and Future

10h30 - 11h30 Keynote Lecture - Medical Research Beyond Invasive Animal Studies: A Paradigm Shift in Clinical Trials - Dr. Phillip Low
11h30 - 12h00 Field and lab behavioural studies: an ethical approach - Dr. Luis Vicente
12h00 - 12h30 Humanising drug safety testing: a pragmatic validation study - Dr. Robert Coleman
12h30 - 13h00 Open Debate
13h00 - 14h30 Lunch Break

SESSION 2 - The new paths of Europe, for Citizenship and Ethics

14h30 - 15h00 Dr. Ana Paula Martins
15h00 - 15h30 (to be confirmed)
15h30 - 16h00 In vitro methods and strategies for serious eye damage/eye irritation - Dr. Joao Barroso
16h00 - 16h30 (to be confirmed)
16h30 - 17h00 The NOTOX Project - The Challenge of in vitro to in vivo Extrapolation - Dr. Elmar Heinzle
17h00 - 18h30 Coffee Break and Poster Sessions
20h00 Conference Dinner

9TH MAY 2015

SESSION 3 - The Emergence of Alternatives - in vitro Technology

10h00 - 11h00 Keynote lecture - Driving alternative approaches to skin and respiratory sensitisation - Dr. Ian Kimber
11h00 - 11h30 In vitro approaches for detection of chemical sensitization - Dr. Teresa Rosete
11h30 - 12h00 Reconstructed human 3D tissue models for the assessment of substances and formulations in vitro - Dr. Helena Kandarova
12h00 - 12h30 Targeting the stem cell population in chronic myeloid leukaemia - Dr. Helen Wheadon
12h30 - 13h00 Open Debate
13h00 - 14h30 Lunch Break

SESSION 4 - The Emergence Of Alternatives - in silico Models

14h30 - 15h00 In Silico approaches to predict organ level toxicity: findings of the COSMOS Project - Dr. Mark Cronin
15h00 - 15h30 Re-thinking drug design: In-Silico, systems pharmacology approach to study the effect of statins on the early stage of atherosclerosis in humans - Dr. Vanessa Diaz
15h30 - 16h00 Genome-scale constraint-based modeling in biomedical research - Dr. Miguel Rocha
16h00 - 16h30 Coffee break and Poster Sessions

SESSION 5 - Clinical Research

16h30 - 17h00 Defining the clinical research question: unnecessary repetition of animal studies: the case of fetal monitoring - Dr. Diogo Ayres-de-Campos
17h00 - 17h30 ADHD: what have we learned from clinical research and animal studies? - Dr. Constanca Carvalho